Increased reliance on credit-based private markets: Medical students will now be more likely to bridge the remaining annual balance through private student lenders. Unlike federal loans, private lending relies heavily on credit scores and debt-to-income ratios. Many incoming medical students will lack the robust credit history or immediate income to qualify for favorable terms independently, meaning they’ll need a co-signer or take out loans with variable, higher-risk interest rates.
Loss of sovereign protections: Private loans do not qualify for Income-Driven Repayment (IDR) frameworks or Public Service Loan Forgiveness. While the final version of the OBBB preserved PSLF eligibility for time spent in medical residency, the portion of debt funded privately cannot be forgiven through public service.
Grandfathering mechanics for current students: Students already enrolled and holding a federal loan before July 1 fall under a strict grandfathering clause. They can continue utilizing Grad PLUS loans and previous aggregate limits for up to three academic years or until graduation, whichever comes first, provided they maintain continuous enrollment. Taking an unapproved leave of absence will immediately revoke this status.
Systemic institutional pressure: Medical schools and specialty programs likely will face immense pressure to reevaluate their pricing, especially those with models built on the assumption of unlimited federal Grad PLUS borrowing. Without providing alternatives, such as institutional scholarship endowments, they risk severely shrinking their applicant pools, especially among lower-income and rural students.
The national private medical student loan landscape: To fill the funding gap created by the elimination of Federal Grad PLUS loans, national private lenders have structured tier-based interest rates. However, the lowest advertised rates require exceptional credit or a highly qualified co-signer.